Table 3 LOCF-method vs. Completers/non-Completers analyses of cardio pulmonary exercise test derived variables: changes between last measurement and baseline
From: Lung function in idiopathic pulmonary fibrosis - extended analyses of the IFIGENIA trial
LOCF-method | Completers | Non-Completers | ||||
|---|---|---|---|---|---|---|
NAC | PLA | NAC | PLA | NAC | PLA | |
W'max (W) | -3.693 | -11.136 | -1.259 | -11.183 | -19.262 | -10.826 |
± SE | ± 3.534 | ± 3.382 | ± 3.90 | ± 3.849 | ± 6.056 | ± 4.944 |
n = | 44 | 48 | 38 | 39 | 6 | 9 |
p = | 0.30 | 0.0014 | 0.75 | 0.0048 | 0.0079 | 0.0049 |
V'CO2max (L/min) | 0.035 | -0.138 | 0.0833 | -0.141 | -0.207 | -0.128 |
± SE | ± 0.0579 | ± 0.0548 | ± 0.0632 | ± 0.0599 | ± 0.127 | ± 0.118 |
n = | 43 | 48 | 36 | 40 | 7 | 8 |
p = | 0.55 | 0.014 | 0.19 | 0.022 | 0.13 | 0.30 |
V'O2max (L/min) | 0.004 | -0.121 | 0.0833 | -0.141 | -0.231 | -0.105 |
± SE | ± 0.050 | ± 0.048 | ± 0.056 | 0.054 | 0.108 | 0.095 |
n = | 44 | 48 | 37 | 39 | 7 | 9 |
p = | 0.93 | 0.014 | 0.39 | 0.025 | 0.051 | 0.29 |
V'O2max (% pred.) | -2.411 | -8.628 | -0.950 | -9.473 | -10.090 | -4.993 |
± SE | ± 2.554 | ± 2.445 | ± 2.786 | ± 2.713 | ± 5.180 | ± 4.562 |
n = | 44 | 48 | 37 | 39 | 7 | 9 |
p = | 0.35 | 0.0007 | 0.73 | 0.0008 | 0.073 | 0.29 |